期刊
MOLECULAR NUTRITION & FOOD RESEARCH
卷 65, 期 5, 页码 -出版社
WILEY
DOI: 10.1002/mnfr.202000023
关键词
alcoholic liver disease; microbiome; mycobiome
资金
- NIH [R01 AA24726, R01AA020703, U01 AA026939]
- Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [BX004594]
- San Diego Digestive Diseases Research Center [P30 DK120515]
- Biocodex Microbiota Foundation
Alcohol-related liver disease is associated with dysregulations in the intestinal barrier function and gut microbiota, communicating with the liver through the gut-liver axis. Some microbial products and metabolites reviewed in this article may serve as therapeutic targets for alcohol-related liver disease.
As a serious public health concern, alcohol-related liver disease is associated with dysregulations in the intestinal barrier function and the gut microbiota. The liver and gut communicate via the gut-liver axis, through which microbial products and metabolites translocate to the liver. Here, the current knowledge of various microbial products and metabolites which contribute to the alcohol-related liver diseases, including bile acids, indole-3-acetic acid, butyrate, long-chain fatty acids, endotoxin, cytolysin, beta-glucan, and candidalysin is reviewed. Some of these might serve as therapeutic targets for alcohol-related liver disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据